3,376 Shares in Waters Corporation $WAT Acquired by Jacobs Levy Equity Management Inc.

Jacobs Levy Equity Management Inc. purchased a new position in shares of Waters Corporation (NYSE:WAT) in the 1st quarter, according to its most recent Form 13F filing with the SEC. The firm purchased 3,376 shares of the medical instruments supplier’s stock, valued at approximately $1,244,000.

Other hedge funds have also added to or reduced their stakes in the company. Olde Wealth Management LLC acquired a new stake in Waters during the 1st quarter worth approximately $25,000. Zions Bancorporation National Association UT acquired a new stake in Waters during the 1st quarter worth approximately $28,000. IFP Advisors Inc lifted its holdings in Waters by 118.9% during the 1st quarter. IFP Advisors Inc now owns 81 shares of the medical instruments supplier’s stock worth $30,000 after purchasing an additional 44 shares during the last quarter. Whipplewood Advisors LLC lifted its holdings in Waters by 5,200.0% during the 1st quarter. Whipplewood Advisors LLC now owns 106 shares of the medical instruments supplier’s stock worth $39,000 after purchasing an additional 104 shares during the last quarter. Finally, Caitong International Asset Management Co. Ltd bought a new stake in shares of Waters in the first quarter valued at approximately $41,000. 94.01% of the stock is owned by institutional investors and hedge funds.

Waters Trading Up 3.4%

Shares of WAT stock opened at $302.95 on Friday. The firm has a market capitalization of $18.03 billion, a P/E ratio of 27.32, a P/E/G ratio of 2.73 and a beta of 1.07. Waters Corporation has a twelve month low of $275.05 and a twelve month high of $423.56. The company has a quick ratio of 1.22, a current ratio of 1.75 and a debt-to-equity ratio of 0.55. The stock’s fifty day simple moving average is $300.75 and its 200 day simple moving average is $333.97.

Waters (NYSE:WAT) last issued its quarterly earnings data on Monday, August 4th. The medical instruments supplier reported $2.95 earnings per share for the quarter, topping analysts’ consensus estimates of $2.93 by $0.02. The business had revenue of $771.33 million for the quarter, compared to analyst estimates of $745.96 million. Waters had a return on equity of 38.60% and a net margin of 21.71%.Waters’s quarterly revenue was up 8.8% compared to the same quarter last year. During the same quarter in the previous year, the company posted $2.63 EPS. Waters has set its Q3 2025 guidance at 3.150-3.250 EPS. FY 2025 guidance at 12.950-13.050 EPS. As a group, sell-side analysts predict that Waters Corporation will post 12.86 EPS for the current fiscal year.

Analysts Set New Price Targets

Several equities research analysts recently issued reports on WAT shares. Scotiabank reiterated a “sector outperform” rating and issued a $465.00 price target on shares of Waters in a research note on Friday, July 11th. Bank of America lifted their price objective on Waters from $370.00 to $375.00 and gave the company a “neutral” rating in a report on Thursday, June 26th. Wells Fargo & Company dropped their price objective on Waters from $330.00 to $315.00 and set an “equal weight” rating for the company in a report on Tuesday, August 5th. Wall Street Zen cut Waters from a “buy” rating to a “hold” rating in a report on Saturday, July 26th. Finally, Jefferies Financial Group set a $385.00 price objective on Waters and gave the company a “buy” rating in a report on Monday, August 4th. One investment analyst has rated the stock with a Strong Buy rating, five have given a Buy rating and nine have given a Hold rating to the company’s stock. According to MarketBeat, the stock has a consensus rating of “Hold” and an average target price of $378.73.

Waters Profile

Waters Corporation provides analytical workflow solutions in Asia, the Americas, and Europe. It operates through two segments: Waters and TA. The company designs, manufactures, sells, and services high and ultra-performance liquid chromatography, as well as mass spectrometry (MS) technology systems and support products, including chromatography columns, other consumable products, and post-warranty service plans.